Moxetumomab Pasudotox-tdfk and Valproate Injection
Determining the interaction of Moxetumomab Pasudotox-tdfk and Valproate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproic acid, Valproic Acid and Derivatives
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Valproate sodium Intravenous
- Moxetumomab Pasudotox-tdfk-Valproic acid
- Moxetumomab Pasudotox-tdfk-Valproic Acid and Derivatives
- Moxetumomab Pasudotox-tdfk-Valproic Acid Capsules
- Moxetumomab Pasudotox-tdfk-Valproic Acid Liquid
- Moxetumomab Pasudotox-tdfk-Valproic Acid Oral Solution
- Valproate Injection-Moxetumomab pasudotox-tdfk Intravenous
- Valproate Injection-Moxifloxacin
- Valproate Injection-Moxifloxacin (Systemic)
- Valproate Injection-Moxifloxacin Hydrochloride
- Valproate Injection-Moxifloxacin Injection
- Valproate Injection-Moxifloxacin Intravenous